speb/financial-data huggingface dataset:
CBAN balance_sheet (annual, 2024-12-31) — Gross PPE: 72320000.00
CBAN balance_sheet (quarterly, 2024-12-31) — Gross PPE: 72320000.00
CBAN balance_sheet (annual, 2024-12-31) — Held To Maturity Securities: 430077000.00
CBAN cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 4717000.00
CBAN income_statement (annual, 2024-12-31) — Interest Expense: 61165000.00
CBAN income_statement (annual, 2024-12-31) — Interest Income: 137241000.00
CBAN cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 61754000.00
CBAN balance_sheet (annual, 2024-12-31) — Invested Capital: 526714000.00
CBAN cash_flow (annual, 2024-12-31) — Investing Cash Flow: 101158000.00
CBAN balance_sheet (annual, 2024-12-31) — Investments And Advances: 813820000.00
CBAN cash_flow (annual, 2024-12-31) — Issuance Of Debt: 290000000.00
CBAN balance_sheet (annual, 2024-12-31) — Land And Improvements: 11314000.00
CBAN balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 11314000.00
CBAN balance_sheet (annual, 2024-12-31) — Leases: 1392000.00
CBAN balance_sheet (quarterly, 2024-12-31) — Leases: 1392000.00
CBAN balance_sheet (annual, 2024-12-31) — Long Term Debt: 248039000.00
CBAN balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 248039000.00
CBAN cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 290000000.00
CBAN cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -280500000.00
CBAN balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 21203000.00
CBAN balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 21203000.00
CBAN cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
CBAN cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -1305000.00
CBAN cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: -540000.00
CBAN balance_sheet (annual, 2024-12-31) — Net Debt: 221994000.00
CBAN balance_sheet (quarterly, 2024-12-31) — Net Debt: 221994000.00
CBAN income_statement (annual, 2024-12-31) — Net Income: 23868000.00
CBAN income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 23868000.00
CBAN income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 23868000.00
CBAN income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 23868000.00
CBAN income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 23868000.00
CBAN cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 23868000.00
CBAN income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 23868000.00
CBAN income_statement (annual, 2024-12-31) — Net Interest Income: 76076000.00
CBAN cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 63801000.00
CBAN cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 9500000.00
CBAN cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 9500000.00
CBAN cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -296000.00
CBAN cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 1394000.00
CBAN balance_sheet (annual, 2024-12-31) — Net PPE: 37831000.00
CBAN cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -1003000.00
CBAN balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 226777000.00
CBAN income_statement (annual, 2024-12-31) — Normalized Income: 23868000.00
CBAN income_statement (annual, 2024-12-31) — Occupancy And Equipment: 6149000.00
CBAN cash_flow (annual, 2024-12-31) — Operating Cash Flow: 23401000.00
CBAN cash_flow (annual, 2024-12-31) — Operating Gains Losses: -7672000.00
CBAN income_statement (annual, 2024-12-31) — Operating Revenue: 115451000.00
CBAN balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 17519884.00
CBAN balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -47567000.00
CBAN balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 2975000.00
CBAN cash_flow (annual, 2024-12-31) — Other Non Cash Items: -4211000.00
CBAN income_statement (annual, 2024-12-31) — Other Non Interest Expense: 20084000.00
CBAN balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 366049000.00
CBAN balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
CBAN income_statement (annual, 2024-12-31) — Pretax Income: 29567000.00
CBAN income_statement (annual, 2024-12-31) — Professional Expense And Contract Services Expense: 2825000.00
CBAN cash_flow (annual, 2024-12-31) — Purchase Of Investment: -56616000.00
CBAN cash_flow (annual, 2024-12-31) — Purchase Of PPE: -1080000.00
CBAN income_statement (annual, 2024-12-31) — Reconciled Depreciation: 8130000.00
CBAN cash_flow (annual, 2024-12-31) — Repayment Of Debt: -280500000.00
CBAN cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -1305000.00
CBAN cash_flow (quarterly, 2024-12-31) — Repurchase Of Capital Stock: -540000.00
CBAN balance_sheet (annual, 2024-12-31) — Retained Earnings: 140369000.00
CBAN income_statement (annual, 2024-12-31) — Salaries And Wages: 49767000.00
CBAN cash_flow (annual, 2024-12-31) — Sale Of Business: 0.00
CBAN cash_flow (annual, 2024-12-31) — Sale Of Investment: 120417000.00
CBAN cash_flow (annual, 2024-12-31) — Sale Of PPE: 77000.00
CBAN income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 4009000.00
CBAN income_statement (annual, 2024-12-31) — Selling General And Administration: 53776000.00
CBAN balance_sheet (annual, 2024-12-31) — Share Issued: 17519884.00
CBAN cash_flow (annual, 2024-12-31) — Stock Based Compensation: 1296000.00
CBAN balance_sheet (annual, 2024-12-31) — Stockholders Equity: 278675000.00
CBAN balance_sheet (annual, 2024-12-31) — Tangible Book Value: 226777000.00
CBAN income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CBAN income_statement (annual, 2024-12-31) — Tax Provision: 5699000.00
CBAN income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.19
CBAN balance_sheet (annual, 2024-12-31) — Total Assets: 3109782000.00
CBAN balance_sheet (annual, 2024-12-31) — Total Capitalization: 526714000.00
CBAN balance_sheet (annual, 2024-12-31) — Total Debt: 248039000.00
CBAN balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 278675000.00
CBAN balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 2831107000.00
CBAN income_statement (quarterly, 2025-03-31) — +Total Revenue: 29996000.00
CBAN balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 167876000.00
CBAN balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 17822000.00
CBAN income_statement (quarterly, 2025-03-31) — Basic Average Shares: 17509059.00
CBAN income_statement (quarterly, 2025-03-31) — Basic EPS: 0.38
CBAN cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 231034000.00
CBAN cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -346000.00
CBAN balance_sheet (quarterly, 2025-03-31) — Capital Stock: 17482000.00
CBAN balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 26093000.00
CBAN balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 221205000.00
CBAN cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -2015000.00
CBAN balance_sheet (quarterly, 2025-03-31) — Cash Financial: 26093000.00
CBAN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 51866000.00
CBAN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -79640000.00
CBAN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 17945000.00
CBAN cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -5780000.00
CBAN cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -898000.00
CBAN cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -412000.00
CBAN cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -7090000.00
CBAN cash_flow (quarterly, 2025-03-31) — Changes In Cash: -9829000.00
CBAN balance_sheet (quarterly, 2025-03-31) — Common Stock: 17482000.00
CBAN cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -2015000.00
CBAN balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 286925000.00
CBAN cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -630000.00
CBAN cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 62000.00
CBAN cash_flow (quarterly, 2025-03-31) — Deferred Tax: 62000.00
CBAN cash_flow (quarterly, 2025-03-31) — Depreciation: 1778000.00
CBAN cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 1778000.00
CBAN cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 1778000.00
CBAN income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 17509059.00
CBAN income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.38
CBAN income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 6613000.00
CBAN cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: -90000.00
CBAN cash_flow (quarterly, 2025-03-31) — End Cash Position: 221205000.00
CBAN cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 51866000.00
CBAN cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 17599000.00
CBAN cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 0.00
CBAN cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 0.00
CBAN income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 0.00
CBAN balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -43400000.00
CBAN income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 11905000.00
CBAN balance_sheet (quarterly, 2025-03-31) — Goodwill: 48923000.00
CBAN balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 51625000.00
CBAN balance_sheet (quarterly, 2025-03-31) — Held To Maturity Securities: 421894000.00
CBAN cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 7000.00
CBAN income_statement (quarterly, 2025-03-31) — Interest Expense: 14573000.00
CBAN income_statement (quarterly, 2025-03-31) — Interest Income: 35525000.00
CBAN cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 14020000.00
CBAN balance_sheet (quarterly, 2025-03-31) — Invested Capital: 471925000.00
CBAN cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -79640000.00
CBAN balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 820421000.00
CBAN cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 50000000.00
CBAN balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 185000000.00
CBAN balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 185000000.00
CBAN cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 50000000.00
CBAN cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -50000000.00
CBAN cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -630000.00
CBAN balance_sheet (quarterly, 2025-03-31) — Net Debt: 158907000.00
CBAN income_statement (quarterly, 2025-03-31) — Net Income: 6613000.00
CBAN income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 6613000.00
CBAN income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 6613000.00
CBAN income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 6613000.00
CBAN income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 6613000.00
CBAN cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 6613000.00
CBAN income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 6613000.00
CBAN income_statement (quarterly, 2025-03-31) — Net Interest Income: 20952000.00
CBAN cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -830000.00
CBAN cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 0.00
CBAN cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 0.00
CBAN cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -77000.00
CBAN cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 765000.00
CBAN balance_sheet (quarterly, 2025-03-31) — Net PPE: 36433000.00
CBAN cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -346000.00
CBAN balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 235300000.00
CBAN income_statement (quarterly, 2025-03-31) — Normalized Income: 6613000.00
CBAN income_statement (quarterly, 2025-03-31) — Occupancy And Equipment: 1580000.00
CBAN cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 17945000.00
CBAN cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -1125000.00
CBAN income_statement (quarterly, 2025-03-31) — Operating Revenue: 29996000.00
CBAN balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 17481709.00
CBAN balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -43400000.00
CBAN balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 2702000.00
CBAN cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 16015000.00
CBAN income_statement (quarterly, 2025-03-31) — Other Non Interest Expense: 5183000.00
CBAN balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 380705000.00
CBAN balance_sheet (quarterly, 2025-03-31) — Preferred Securities Outside Stock Equity: 63062000.00
CBAN balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
CBAN income_statement (quarterly, 2025-03-31) — Pretax Income: 8275000.00
CBAN income_statement (quarterly, 2025-03-31) — Professional Expense And Contract Services Expense: 748000.00
CBAN cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -22372000.00
CBAN cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -346000.00
CBAN income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 1778000.00
CBAN cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -50000000.00
CBAN cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -630000.00
CBAN income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 0.00
CBAN balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 144967000.00
CBAN income_statement (quarterly, 2025-03-31) — Salaries And Wages: 11905000.00
CBAN cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 21542000.00
CBAN cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 0.00
CBAN income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 805000.00
CBAN income_statement (quarterly, 2025-03-31) — Selling General And Administration: 12710000.00
CBAN balance_sheet (quarterly, 2025-03-31) — Share Issued: 17481709.00
CBAN income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
CBAN cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 192000.00
CBAN balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 286925000.00
CBAN balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 235300000.00
CBAN income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CBAN income_statement (quarterly, 2025-03-31) — Tax Provision: 1662000.00
CBAN income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.20
CBAN balance_sheet (quarterly, 2025-03-31) — Total Assets: 3171825000.00
CBAN balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 471925000.00
CBAN balance_sheet (quarterly, 2025-03-31) — Total Debt: 185000000.00
CBAN balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 286925000.00
CBAN balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 2884900000.00
CBAN income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
CBAN income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
CBAN income_statement (quarterly, 2025-06-30) — +Total Revenue: 32483000.00
CBAN balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 167160000.00
CBAN balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 170152000.00
CBAN income_statement (quarterly, 2025-06-30) — Basic Average Shares: 17448945.00
CBAN income_statement (quarterly, 2025-06-30) — Basic EPS: 0.46
CBAN cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 221205000.00
CBAN cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -85000.00
CBAN balance_sheet (quarterly, 2025-06-30) — Capital Stock: 17417000.00
CBAN balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 27590000.00
CBAN balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 112145000.00
CBAN cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -2007000.00
CBAN balance_sheet (quarterly, 2025-06-30) — Cash Financial: 27590000.00
CBAN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -69267000.00
CBAN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -55636000.00
CBAN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 15843000.00
CBAN cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -66000.00
CBAN cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 2583000.00
CBAN cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -429000.00
CBAN cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 2088000.00
CBAN cash_flow (quarterly, 2025-06-30) — Changes In Cash: -109060000.00
CBAN balance_sheet (quarterly, 2025-06-30) — Common Stock: 17417000.00
CBAN cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -2007000.00
CBAN balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 293857000.00
CBAN cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 408000.00
CBAN cash_flow (quarterly, 2025-06-30) — Deferred Tax: 408000.00
CBAN cash_flow (quarterly, 2025-06-30) — Depreciation: 1778000.00
CBAN cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 1778000.00
CBAN cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 1778000.00
CBAN income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 17448945.00
CBAN income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.46
CBAN income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 7978000.00
CBAN cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: -105000.00
CBAN cash_flow (quarterly, 2025-06-30) — End Cash Position: 112145000.00
CBAN cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -69267000.00
CBAN cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 15758000.00
CBAN cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 0.00
CBAN cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: 0.00
CBAN income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 0.00
CBAN balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -41658000.00
CBAN income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 12865000.00
CBAN balance_sheet (quarterly, 2025-06-30) — Goodwill: 50871000.00
CBAN balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 54670000.00
CBAN balance_sheet (quarterly, 2025-06-30) — Held To Maturity Securities: 379963000.00
CBAN cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 2013000.00
CBAN income_statement (quarterly, 2025-06-30) — Interest Expense: 14450000.00
CBAN income_statement (quarterly, 2025-06-30) — Interest Income: 36835000.00
CBAN cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 14634000.00
CBAN balance_sheet (quarterly, 2025-06-30) — Invested Capital: 478857000.00
CBAN cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -55636000.00
CBAN balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 801133000.00
CBAN cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 50000000.00
CBAN balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 185000000.00
CBAN balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 185000000.00
CBAN cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 50000000.00
CBAN cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -50000000.00
CBAN balance_sheet (quarterly, 2025-06-30) — Net Debt: 157410000.00
CBAN income_statement (quarterly, 2025-06-30) — Net Income: 7978000.00
CBAN income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 7978000.00
CBAN income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 7978000.00
CBAN income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 7978000.00
CBAN income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 7978000.00
CBAN cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 7978000.00
CBAN income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 7978000.00
CBAN income_statement (quarterly, 2025-06-30) — Net Interest Income: 22385000.00
CBAN cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 21281000.00
CBAN cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 0.00
CBAN cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 0.00
CBAN cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 0.00
CBAN cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -2960000.00
CBAN balance_sheet (quarterly, 2025-06-30) — Net PPE: 35909000.00
CBAN cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -85000.00
CBAN balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 239187000.00
CBAN income_statement (quarterly, 2025-06-30) — Normalized Income: 7978000.00
CBAN income_statement (quarterly, 2025-06-30) — Occupancy And Equipment: 1683000.00
CBAN cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 15843000.00
CBAN cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -1655000.00
CBAN income_statement (quarterly, 2025-06-30) — Operating Revenue: 32483000.00
CBAN balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 17416702.00
CBAN balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -41658000.00
CBAN balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 3799000.00
CBAN cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 4618000.00
CBAN income_statement (quarterly, 2025-06-30) — Other Non Interest Expense: 5772000.00
CBAN balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 251018000.00
CBAN balance_sheet (quarterly, 2025-06-30) — Preferred Securities Outside Stock Equity: 63086000.00
CBAN balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
CBAN income_statement (quarterly, 2025-06-30) — Pretax Income: 10029000.00
CBAN income_statement (quarterly, 2025-06-30) — Professional Expense And Contract Services Expense: 742000.00
CBAN cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -5838000.00
CBAN cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -85000.00
CBAN income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 1778000.00
CBAN cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -50000000.00
CBAN balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 150938000.00
CBAN income_statement (quarterly, 2025-06-30) — Salaries And Wages: 12865000.00
CBAN cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 27119000.00
CBAN cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 0.00
CBAN income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 942000.00
CBAN income_statement (quarterly, 2025-06-30) — Selling General And Administration: 13807000.00
CBAN balance_sheet (quarterly, 2025-06-30) — Share Issued: 17416702.00
CBAN cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 178000.00
CBAN balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 293857000.00
CBAN balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 239187000.00
CBAN income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CBAN income_statement (quarterly, 2025-06-30) — Tax Provision: 2051000.00
CBAN income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
CBAN balance_sheet (quarterly, 2025-06-30) — Total Assets: 3115617000.00
CBAN balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 478857000.00
CBAN balance_sheet (quarterly, 2025-06-30) — Total Debt: 185000000.00
CBAN balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 293857000.00
CBAN balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 2821760000.00
CBAN income_statement (quarterly, 2025-09-30) — +Total Revenue: 32790000.00
CBAN balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 167096000.00
CBAN cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 0.00
CBAN balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 170526000.00
CBAN income_statement (quarterly, 2025-09-30) — Basic Average Shares: 17461434.00
CBAN income_statement (quarterly, 2025-09-30) — Basic EPS: 0.33
CBAN cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 112145000.00
CBAN cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -351000.00
CBAN balance_sheet (quarterly, 2025-09-30) — Capital Stock: 17461000.00
CBAN balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 25291000.00
CBAN balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Federal Funds Sold: 199966000.00
CBAN cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -2009000.00
CBAN balance_sheet (quarterly, 2025-09-30) — Cash Financial: 25291000.00
CBAN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 25866000.00
CBAN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 47544000.00
CBAN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 14411000.00
CBAN cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 1623000.00
CBAN cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 333000.00
CBAN cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -396000.00
CBAN cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 1560000.00
CBAN cash_flow (quarterly, 2025-09-30) — Changes In Cash: 87821000.00
CBAN balance_sheet (quarterly, 2025-09-30) — Common Stock: 17461000.00
CBAN cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -2009000.00
CBAN balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 302332000.00
CBAN cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 571000.00
CBAN cash_flow (quarterly, 2025-09-30) — Deferred Tax: 571000.00
CBAN cash_flow (quarterly, 2025-09-30) — Depreciation: 1863000.00
CBAN cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 1863000.00
CBAN cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 1863000.00
CBAN income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 17461434.00
CBAN income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.33
CBAN income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 5819000.00
CBAN cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: -72000.00
CBAN cash_flow (quarterly, 2025-09-30) — End Cash Position: 199966000.00
CBAN cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 25866000.00
CBAN cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 14060000.00
CBAN cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 1039000.00
CBAN cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 0.00
CBAN income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -1039000.00
CBAN balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -36973000.00
CBAN income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 13532000.00
CBAN balance_sheet (quarterly, 2025-09-30) — Goodwill: 50871000.00
CBAN balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 54415000.00
CBAN balance_sheet (quarterly, 2025-09-30) — Held To Maturity Securities: 377283000.00
CBAN cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 1767000.00
CBAN income_statement (quarterly, 2025-09-30) — Interest Expense: 14193000.00
CBAN income_statement (quarterly, 2025-09-30) — Interest Income: 36892000.00
CBAN cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 14326000.00
CBAN balance_sheet (quarterly, 2025-09-30) — Invested Capital: 487332000.00
CBAN cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 47544000.00
CBAN balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 712393000.00
CBAN cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 125000000.00
CBAN balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 185000000.00
CBAN balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 185000000.00
CBAN cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 125000000.00
CBAN cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -125000000.00
CBAN balance_sheet (quarterly, 2025-09-30) — Net Debt: 159709000.00
CBAN income_statement (quarterly, 2025-09-30) — Net Income: 5819000.00
CBAN income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 5819000.00
CBAN income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 5819000.00
CBAN income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 5819000.00
CBAN income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 5819000.00
CBAN cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 5819000.00
CBAN income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 5819000.00
CBAN income_statement (quarterly, 2025-09-30) — Net Interest Income: 22699000.00
CBAN cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 93223000.00
CBAN cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 0.00
CBAN cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 0.00
CBAN cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -224000.00
CBAN cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 0.00
CBAN balance_sheet (quarterly, 2025-09-30) — Net PPE: 35604000.00
CBAN cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -351000.00
CBAN balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 247917000.00
CBAN income_statement (quarterly, 2025-09-30) — Normalized Income: 6404600.00
CBAN income_statement (quarterly, 2025-09-30) — Occupancy And Equipment: 1732000.00
CBAN cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 14411000.00
CBAN cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -444000.00
CBAN income_statement (quarterly, 2025-09-30) — Operating Revenue: 32790000.00
CBAN balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 17461284.00
CBAN balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -36973000.00
CBAN balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 3544000.00
CBAN cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 3938000.00
CBAN income_statement (quarterly, 2025-09-30) — Other Non Interest Expense: 6488000.00
CBAN balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 164584000.00
CBAN balance_sheet (quarterly, 2025-09-30) — Preferred Securities Outside Stock Equity: 63109000.00
CBAN balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
CBAN income_statement (quarterly, 2025-09-30) — Pretax Income: 7278000.00
CBAN income_statement (quarterly, 2025-09-30) — Professional Expense And Contract Services Expense: 998000.00
CBAN cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -2761000.00
CBAN cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -351000.00
CBAN income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 1863000.00
CBAN cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -125000000.00
CBAN income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 732000.00
CBAN balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 154748000.00
CBAN income_statement (quarterly, 2025-09-30) — Salaries And Wages: 13532000.00
CBAN cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 95984000.00
CBAN cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 0.00
CBAN income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 1130000.00
CBAN income_statement (quarterly, 2025-09-30) — Selling General And Administration: 14662000.00
CBAN balance_sheet (quarterly, 2025-09-30) — Share Issued: 17461284.00
CBAN income_statement (quarterly, 2025-09-30) — Special Income Charges: -732000.00
CBAN cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 204000.00
CBAN balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 302332000.00
CBAN balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 247917000.00
CBAN income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -146400.00
CBAN income_statement (quarterly, 2025-09-30) — Tax Provision: 1459000.00
CBAN income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.20
CBAN balance_sheet (quarterly, 2025-09-30) — Total Assets: 3152746000.00
CBAN balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 487332000.00
CBAN balance_sheet (quarterly, 2025-09-30) — Total Debt: 185000000.00
CBAN balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 302332000.00
CBAN balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 2850414000.00
CBAN income_statement (quarterly, 2025-09-30) — Total Unusual Items: -732000.00
CBAN income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -732000.00
CBAN income_statement (annual, 2025-12-31) — +Total Revenue: 132181000.00
CBAN income_statement (quarterly, 2025-12-31) — +Total Revenue: 36912000.00
CBAN balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -36070000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -36070000.00
CBAN balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 228577000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 228577000.00
CBAN cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 0.00
CBAN cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
CBAN balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 189732000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 189732000.00
CBAN income_statement (annual, 2025-12-31) — Basic Average Shares: 17789688.00
CBAN income_statement (quarterly, 2025-12-31) — Basic Average Shares: 18729511.00
CBAN income_statement (annual, 2025-12-31) — Basic EPS: 1.59
CBAN income_statement (quarterly, 2025-12-31) — Basic EPS: 0.42
CBAN cash_flow (annual, 2025-12-31) — Beginning Cash Position: 231034000.00
CBAN cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 199966000.00
CBAN balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 36839000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 36839000.00
CBAN cash_flow (annual, 2025-12-31) — Capital Expenditure: -1354000.00
CBAN cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -572000.00
CBAN balance_sheet (annual, 2025-12-31) — Capital Stock: 21252000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Capital Stock: 21252000.00
CBAN balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 27307000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 27307000.00
CBAN balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 257640000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 257640000.00
CBAN cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -8038000.00
CBAN cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -2007000.00
CBAN balance_sheet (annual, 2025-12-31) — Cash Financial: 27307000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Cash Financial: 27307000.00
CBAN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 28742000.00
CBAN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 20277000.00
CBAN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 3409000.00
CBAN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 91141000.00
CBAN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -5545000.00
CBAN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -53744000.00
CBAN cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -8999000.00
CBAN cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -4776000.00
CBAN cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 443000.00
CBAN cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -1575000.00
CBAN cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -1792000.00
CBAN cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -555000.00
CBAN cash_flow (annual, 2025-12-31) — Change In Working Capital: -10348000.00
CBAN cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -6906000.00
CBAN cash_flow (annual, 2025-12-31) — Changes In Cash: 26606000.00
CBAN cash_flow (quarterly, 2025-12-31) — Changes In Cash: 57674000.00
CBAN balance_sheet (annual, 2025-12-31) — Common Stock: 21252000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Common Stock: 21252000.00
CBAN cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -8038000.00
CBAN cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -2007000.00
CBAN balance_sheet (annual, 2025-12-31) — Common Stock Equity: 375920000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 375920000.00
CBAN cash_flow (annual, 2025-12-31) — Common Stock Payments: -2368000.00
CBAN cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -779000.00
CBAN balance_sheet (annual, 2025-12-31) — Construction In Progress: 19000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 19000.00
CBAN cash_flow (annual, 2025-12-31) — Deferred Income Tax: 2064000.00
CBAN cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 1023000.00
CBAN cash_flow (annual, 2025-12-31) — Deferred Tax: 2064000.00
CBAN cash_flow (quarterly, 2025-12-31) — Deferred Tax: 1023000.00
CBAN cash_flow (annual, 2025-12-31) — Depreciation: 7723000.00
CBAN cash_flow (quarterly, 2025-12-31) — Depreciation: 2304000.00
CBAN cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 7723000.00
CBAN cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 2304000.00
CBAN cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 7723000.00
CBAN cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 2304000.00
CBAN income_statement (annual, 2025-12-31) — Diluted Average Shares: 17789688.00
CBAN income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 18729511.00
CBAN income_statement (annual, 2025-12-31) — Diluted EPS: 1.59
CBAN income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.42
CBAN income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 28253000.00
CBAN income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 7843000.00
CBAN cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: -299000.00
CBAN cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: -32000.00
CBAN cash_flow (annual, 2025-12-31) — End Cash Position: 257640000.00
CBAN cash_flow (quarterly, 2025-12-31) — End Cash Position: 257640000.00
CBAN cash_flow (annual, 2025-12-31) — Financing Cash Flow: 28742000.00
CBAN cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 20277000.00
CBAN cash_flow (annual, 2025-12-31) — Free Cash Flow: -6899000.00
CBAN cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -54316000.00
CBAN cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 1039000.00
CBAN cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 0.00
CBAN cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 0.00
CBAN cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 0.00
CBAN income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -1039000.00
CBAN income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 0.00
CBAN balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -34493000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -34493000.00
CBAN income_statement (annual, 2025-12-31) — General And Administrative Expense: 52417000.00
CBAN income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 14115000.00
CBAN balance_sheet (annual, 2025-12-31) — Goodwill: 63873000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Goodwill: 63873000.00
CBAN balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 71724000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 71724000.00
CBAN balance_sheet (annual, 2025-12-31) — Gross PPE: 73115000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Gross PPE: 73115000.00
CBAN balance_sheet (annual, 2025-12-31) — Held To Maturity Securities: 374691000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Held To Maturity Securities: 374691000.00
CBAN cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 4436000.00
CBAN cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 649000.00
CBAN income_statement (annual, 2025-12-31) — Interest Expense: 58051000.00
CBAN income_statement (quarterly, 2025-12-31) — Interest Expense: 14835000.00
CBAN income_statement (annual, 2025-12-31) — Interest Income: 149952000.00
CBAN income_statement (quarterly, 2025-12-31) — Interest Income: 40700000.00
CBAN cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 57288000.00
CBAN cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 14308000.00
CBAN balance_sheet (annual, 2025-12-31) — Invested Capital: 634024000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Invested Capital: 634024000.00
CBAN cash_flow (annual, 2025-12-31) — Investing Cash Flow: 3409000.00
CBAN cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 91141000.00
CBAN balance_sheet (annual, 2025-12-31) — Investments And Advances: 789611000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 789611000.00
CBAN cash_flow (annual, 2025-12-31) — Issuance Of Debt: 275000000.00
CBAN cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 50000000.00
CBAN balance_sheet (annual, 2025-12-31) — Land And Improvements: 11314000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 11314000.00
CBAN balance_sheet (annual, 2025-12-31) — Leases: 2319000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Leases: 2319000.00
CBAN balance_sheet (annual, 2025-12-31) — Long Term Debt: 258104000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 258104000.00
CBAN balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 258104000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 258104000.00
CBAN cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 275000000.00
CBAN cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 50000000.00
CBAN cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -275000000.00
CBAN cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -50000000.00
CBAN balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 22624000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 22624000.00
CBAN cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 916000.00
CBAN cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -2368000.00
CBAN cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -779000.00
CBAN balance_sheet (annual, 2025-12-31) — Net Debt: 230797000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Net Debt: 230797000.00
CBAN income_statement (annual, 2025-12-31) — Net Income: 28253000.00
CBAN income_statement (quarterly, 2025-12-31) — Net Income: 7843000.00
CBAN income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 28253000.00
CBAN income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 7843000.00
CBAN income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 28253000.00
CBAN income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 7843000.00
CBAN income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 28253000.00
CBAN income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 7843000.00
CBAN income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 28253000.00
CBAN income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 7843000.00
CBAN cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 28253000.00
CBAN cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 7843000.00
CBAN income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 28253000.00
CBAN income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 7843000.00
CBAN income_statement (annual, 2025-12-31) — Net Interest Income: 91901000.00
CBAN income_statement (quarterly, 2025-12-31) — Net Interest Income: 25865000.00
CBAN cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 133704000.00
CBAN cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 20030000.00
CBAN cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
CBAN cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
CBAN cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 0.00
CBAN cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 0.00
CBAN cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -311000.00
CBAN cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -10000.00
CBAN cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 2437000.00
CBAN cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 4632000.00
CBAN balance_sheet (annual, 2025-12-31) — Net PPE: 37045000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Net PPE: 37045000.00
CBAN cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -1354000.00
CBAN cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -572000.00
CBAN balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 304196000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 304196000.00
CBAN income_statement (annual, 2025-12-31) — Normalized Income: 29910414.20
CBAN income_statement (quarterly, 2025-12-31) — Normalized Income: 8935749.19
CBAN income_statement (annual, 2025-12-31) — Occupancy And Equipment: 6753000.00
CBAN income_statement (quarterly, 2025-12-31) — Occupancy And Equipment: 1758000.00
CBAN cash_flow (annual, 2025-12-31) — Operating Cash Flow: -5545000.00
CBAN cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -53744000.00
CBAN cash_flow (annual, 2025-12-31) — Operating Gains Losses: -4632000.00
CBAN cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -1408000.00
CBAN income_statement (annual, 2025-12-31) — Operating Revenue: 132181000.00
CBAN income_statement (quarterly, 2025-12-31) — Operating Revenue: 36912000.00
CBAN balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 21251695.00
CBAN balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 21251695.00
CBAN balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -34493000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -34493000.00
CBAN balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 7851000.00
CBAN balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 7851000.00
CBAN cash_flow (annual, 2025-12-31) — Other Non Cash Items: -33890000.00
CBAN cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -58461000.00
CBAN income_statement (annual, 2025-12-31) — Other Non Interest Expense: 23527000.00
CBAN income_statement (quarterly, 2025-12-31) — Other Non Interest Expense: 6084000.00
CBAN balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 225188000.00